Scientists to Study Whether Combination Therapy Reduces Risk of Heart Attacks

---

Omschrijving
Wake Forest University Baptist Medical Center is one of 60 sites in the country participating in a new research study to determine if two medications taken together are better for treating heart disease and stroke. The five-year study, known as AIM-HIGH, will evaluate the effectiveness of prescription extended-release niacin and Zocor taken together – versus taking Zocor alone. The study is being sponsored by the National Heart, Lung and Blood Institute, part of the National Institutes of Health, with support from Abbott Laboratories. The study’s goal is to determine if the combination therapy reduces rates of heart attacks, strokes, and other related events. The Triad has two sites that are enrolling participants: the Department of Internal Medicine-Endocrinology at Wake Forest Baptist and the Kulynych Center for Research, Green Valley Drive, Greensboro.

 

[ Ga naar het volledige artikel toe ]

Categorie: hart

[Reinig uw lichaam met de Chlorella alg - 100% plantaardig ]

Het hoofdmenu
Nieuws
Supervoeding
Zoek op onderwerp